The establishment of PD-1 inhibitor treatment prognosis model based on dynamic changes of peripheral blood indexes in patients with advanced lung squamous cell carcinoma

The establishment of PD-1 inhibitor treatment prognosis model based on dynamic changes of peripheral blood indexes in patients with advanced lung squamous cell carcinoma

BackgroundUnlike patients with lung adenocarcinoma, patients with lung squamous cell carcinoma (LUSC) do not derive significant benefits from targeted therapy. In recent years, immunotherapy has revolutionized the treatment approach for LUSC. However, not all patients with this type of cancer respon...

Full description

Saved in:

Bibliographic Details
Main Authors:	Yuyan Xie, Hao Sun, Liying Shan, Xin Ma, Qingyu Sun, Fang Liu
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-12-01
Series:	Frontiers in Oncology
Subjects:	peripheral blood indexes advanced LUSC immunotherapy PD-1 inhibitor squamous cell carcinoma antigen neuron-specific enolase
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2024.1454709/full
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Comprehensive characterization of PD-L1 expression and immunotherapy-related genomic biomarkers in early- versus advanced-stage non-small cell lung cancer
by: Yujie Chen, et al.
Published: (2025-05-01)

Neuron-specific enolase in the blood serum as a diagnostic marker of Parkinsonism
by: F. F. Gashilova, et al.
Published: (2005-09-01)

Predictive value of serum tumor markers (carcinoembryonic antigen, neuron-specific enolase, and squamous cell carcinoma antigen in non-small cell lung cancer patients treated with programmed cell death protein 1 inhibitors
by: Wang Yang, et al.
Published: (2025-01-01)

Combined CA125, NSE, and multiple inflammatory indices for diagnosis of oral squamous cell carcinoma
by: Kudelaiti Abudukelimu, et al.
Published: (2025-05-01)

Neuron-specific enolase: a potential biomarker in the prediction of pediatric head trauma outcomes: a systematic review and meta-analysis
by: Amir Behforouz, et al.
Published: (2025-07-01)

Neuron specific enolase as a possible indicator of neuron damage in children with acute meningitis
by: L. V. Pypa, et al.
Published: (2018-06-01)

Serum Neuron-specific Enolase Levels in Preterm and Term Newborns and in Infants 1–3 Months of Age
by: Aslihan Abbasoglu, et al.
Published: (2015-04-01)

Non increased neuron-specific enolase concentration in cerebrospinal fluid during first febrile seizures and a year follow-up in pediatric patients
by: ALBERTO J. DORTA-CONTRERAS, et al.
Published: (1998-09-01)

Point-of-Care NSE Biosensor for Objective Assessment of Stroke Risk
by: Cheng Hsu Chen, et al.
Published: (2025-04-01)

Utilizing multi-omics analysis, a new signature has been identified and validated for predicting prognosis and response to immunotherapy in lung squamous cell carcinoma, which is based on tumor mutation burden
by: Dongguang Wang, et al.
Published: (2025-04-01)

Changes neuron-specific enolase and protein S100 in the acute period of tick-borne infections in children
by: G. Yu. Galiyeva, et al.
Published: (2010-08-01)

Neuroimmunological Disturbance Features in Premature Infants with Perinatal Infections
by: Nailya J. Rahimova, et al.
Published: (2018-02-01)

Parity of level neuron-specific enolase and a brain blood-groove at hemispheric ischemic stroke
by: G. M. Karyakina, et al.
Published: (2009-02-01)

Absolute blood levels and kinetics of neurofilament light (NFL) chains for neurological prognosis in comatose patients after cardiac arrest
by: Timothée Ayasse, et al.
Published: (2025-05-01)

Bioinformatics-based modeling of lung squamous cell carcinoma prognosis and prediction of immunotherapy response
by: Qiqing Zhang, et al.
Published: (2024-12-01)

Predictive role of neuron-specific enolase and S100-β in early neurological deterioration and unfavorable prognosis in patients with ischemic stroke
by: Jiang Ruishu, et al.
Published: (2024-12-01)

The level of neuron-specific enolase and S-100 protein in the cerebrospinal fluid of patients with acute bacterial meningitis
by: A. V. Sokhan
Published: (2016-08-01)

Transcranial low-level laser stimulation in the near-infrared-II region (1064 nm) for brain safety in healthy humans
by: Zhilin Li, et al.
Published: (2024-11-01)

SPECIFIC MARKER OF NEURODEGENERATION IN OPTIC NEURITIS DIAGNOSING
by: Kh. M. Kamilov, et al.
Published: (2015-07-01)

Harnessing TAGAP to improve immunotherapy for lung squamous carcinoma treatment by targeting c-Rel in CD4+ T cells
by: Peian Cai, et al.
Published: (2025-02-01)

Prediction of serum neuritin and neuron-specific enolase for prognosis in patients with traumatic brain injury combined with spinal cord injury
by: Pu Bingbing, et al.
Published: (2024-01-01)

Efficacy and safety of PD-1/PD-L1 inhibitors as first-line treatment for esophageal squamous cell carcinoma: a systematic review and meta-analysis
by: Wei Ren, et al.
Published: (2025-03-01)

EVALUATION OF BRAIN-BLOOD BARRIER PERMEABILITY FOR NEURON-SPECIFIC ENOLASE DURING PERINATAL HYPOXIC-ISCHEMIC LESION OF THE CNS
by: D. V. Blinov
Published: (2016-06-01)

PATIENTS WITH NEUROLOGICAL DISEASES: RATIONALE FOR PHARMACOECONOMIC EVALUATION OF COST OPTIMIZATION FOR MANAGEMENT WITH NEURON-SPECIFIC PROTEINS ASSESSMENT AS MARKERS OF INCREASED BLOOD-BRAIN-BARRIER PERMEABILITY
by: D. V. Blinov
Published: (2015-03-01)

Corrigendum: Efficacy and safety of PD-1/PD-L1 inhibitors as first-line treatment for esophageal squamous cell carcinoma: a systematic review and meta-analysis
by: Wei Ren, et al.
Published: (2025-05-01)

Silent Cerebral İnfarction in Anticoagulated Patients with Non-valvular Atrial Fibrillation as Detected with Neuron Specific Enolase
by: Hüseyin Göksülük, et al.
Published: (2018-08-01)

Neuron-Specific Enolase and S100B as Biomarkers of Ischemic Brain Injury During Surgery
by: Matej Makovec, et al.
Published: (2025-04-01)

A panel of cancer testis antigens in squamous cell carcinoma of the lung, head and neck, and esophagus: implication for biomarkers and therapeutic targets
by: Lin Li, et al.
Published: (2025-01-01)

Study on the role of tissue-specific and non-specific autoantibodies, matrix metalloproteinase-3 and neuron-specific enolase enzymes in the exacerbation of autoimmune thyroiditis
by: R. R. Rahimova, et al.
Published: (2024-04-01)

The Influence of Insulin Resistance on the Levels of Neuron Specific Enolase in the Pathogenesis of Obesity-Related Complications
by: Shahad Taher, et al.
Published: (2024-09-01)

The Role of Fibrinogen in Mediating NGAL-Associated Neuronal Damage in Acute Ischemic Stroke: A Moderated Mediation Analysis
by: Zhao N, et al.
Published: (2024-12-01)

Relationship between neuron-specific enolase and swallowing dysfunction in patients with acute ischemic stroke: a single-center retrospective study
by: Danyang Meng, et al.
Published: (2025-05-01)

Establishing Neuron-Specific Enolase Reference Intervals: A Comparative Analysis of Partitioned Approach- and Gender-Based Continuous Age- and Season-Related Models
by: Haibin Zhao, et al.
Published: (2024-10-01)

PD-L1 Inhibitor Cosibelimab for Cutaneous Squamous Cell Carcinoma: Comprehensive Evaluation of Efficacy, Mechanism, and Clinical Trial Insights
by: Omer A. Idris, et al.
Published: (2025-04-01)

Prognostic analysis and identification of M7G immune-related genes in lung squamous cell carcinoma
by: Li Wenhui, et al.
Published: (2025-03-01)

Changes in PD-1 expression on T lymphocyte subsets and related immune indicators before and after definitive chemoradiotherapy for esophageal squamous cell carcinoma
by: Xueling Shi, et al.
Published: (2025-12-01)

Gestational diabetes mellitus and obesity: effects on offspring
by: O. V. Rozhkova, et al.
Published: (2021-07-01)

Diagnostic and prognostic value of neuron-specific enolase and S-100 protein in pediatric viral encephalitis
by: L. A. Alekseeva, et al.
Published: (2023-07-01)

Comparative evaluation of anesthesia methods for reconstructive carotid surgery
by: M. I. Neymark, et al.
Published: (2020-11-01)

An Evaluation of Neuron-Specific Enolase as a Biomarker of Neurological Impact in Pacemaker-Implanted Patients with Atrial High-Rate Episodes: An Observational Study from Turkey
by: Ahmet Cinar, et al.
Published: (2025-02-01)